Status:
COMPLETED
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
Lead Sponsor:
Stanford University
Conditions:
Cancer Survivor
Endometrial Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This randomized phase II trial studies how well a health and recovery program works in increasing physical activity level in stage IA-IIIA endometrial cancer survivors. Health and recovery program whi...
Detailed Description
PRIMARY OBJECTIVES:I. Determine the increase in activity level per participant where the baseline average number of steps is recorded during week 0-2 will be compared to average step count recorded du...
Eligibility Criteria
Inclusion
- Stage IA-IIIA endometrial cancer patients with pathology reviewed at Stanford
- Patients must have undergone surgery as a part of their treatment for their endometrial cancer
- At least 3 months post treatment
- BMI \> 25
- Life expectancy of at least one year
- Able to perform physical activity of walking
- Possession of a computer and/or smart phone and/or smart tablet
- Must be English or Spanish speaking
Exclusion
- Other active cancer
- Receiving chemotherapy or other active treatment
- BMI \< 60
- Diagnosis of uterine serous carcinoma or uterine sarcoma
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2020
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03367923
Start Date
December 1 2017
End Date
March 25 2020
Last Update
November 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University, School of Medicine
Palo Alto, California, United States, 94304
2
Stanford Cancer Center South Bay
San Jose, California, United States, 95124